ConductScience.org, home

Paper1167567

Inhibition by epsilon-aminocaproic acid of the activation of the first component of the complement system.

Soter NA and 2 others. J Immunol, 1975. Cited by 48 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Inhibition by epsilon-aminocaproic acid of the activation of the first component of the complement system. Papers, record 1167567. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1167567

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Inhibition by epsilon-aminocaproic acid of the activation of the first component of the complement system.
PubMed
Journal
J Immunol
PubMed
Year
1975
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
48
iCite
Relative citation ratio, by iCite
1.89
iCite
Revised in PubMed
2013-11-21
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Soter NAN A
2Austen KFK F
3Gigli II

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AminocaproatesMajor topic
Complement Inactivator ProteinsMajor topic
Animals
Erythrocytes
Hemolysis
Humans
Sheep
Trypsin

Source PubMed

Download CSV of topics

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 48 citations.

PMIDTitleJournalYearIn PapersSource
7400327Erythropoietic protoporphyria. Photoactivation of the complement system.J Clin Invest1980https://conductscience.org/library/papers/7400327PubMed
7251063Protection of mice against Mycoplasma pulmonis infection using purified mouse immunoglobulins: comparison between protective effect and biological properties of immunoglobulin classes.Immunology1981https://conductscience.org/library/papers/7251063PubMed
7007210Variation in the susceptibility of bovine mycoplasmas to killing by the alternative complement pathway in bovine serum.Immunology1980https://conductscience.org/library/papers/7007210PubMed
6967051Inhibition of immune complex-mediated activation of complement. Effects of agents modulating activation of, and the activated C1 complex.Inflammation1980https://conductscience.org/library/papers/6967051PubMed
6912799Isolation and characterization of a low molecular weight complement inhibitor present in normal human serum.Clin Exp Immunol1981https://conductscience.org/library/papers/6912799PubMed
2813242Chronic gastrointestinal haemorrhage controlled by antifibrinolytic agents.Postgrad Med J1989https://conductscience.org/library/papers/2813242PubMed
1086286The enhancement of the haemolytic activity of the first component of complement by trasylol.Immunology1976https://conductscience.org/library/papers/1086286PubMed
658981Factors influencing the in vitro interaction between immunoglobulins and isolated C1: a critical study.Immunology1978https://conductscience.org/library/papers/658981PubMed
310809Why do protease inhibitors enhance leucocyte migration inhibition to the antigen PPD?Immunology1978https://conductscience.org/library/papers/310809PubMed
308574Treatment of hereditary angioedema.Klin Wochenschr1978https://conductscience.org/library/papers/308574PubMed
305891Inhibition of the classical and alternative pathways by amino acids and their derivatives.Immunology1978https://conductscience.org/library/papers/305891PubMed
157060Comparative effects of drugs on four paw oedema models in the rat.Agents Actions1979https://conductscience.org/library/papers/157060PubMed
104923Possible mechanisms of the first step of the classical complement activation pathway: binding and activation of C1.Immunology1978https://conductscience.org/library/papers/104923PubMed
75177The requirement of specific antibody for the killing of E. coli by the alternate complement pathway in bovine serum.Immunology1978https://conductscience.org/library/papers/75177PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
HNRNPC3183PubTator's text mininghttps://conductscience.org/library/genes/3183

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1167567

GET https://conductscience.org/api/papers/v1/1167567/authors